| # | Title | Journal | Year | Citations |
|---|
| 1 | Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition | Multiple Sclerosis Journal | 2020 | 965 |
| 2 | International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions | Multiple Sclerosis Journal | 2013 | 883 |
| 3 | The Multiple Sclerosis Functional Composite measure (MSFC): an integrated approach to MS clinical outcome assessment | Multiple Sclerosis Journal | 1999 | 856 |
| 4 | Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis | Multiple Sclerosis Journal | 1999 | 654 |
| 5 | Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) | Multiple Sclerosis Journal | 2012 | 654 |
| 6 | Validity of the Symbol Digit Modalities Test as a cognition performance outcome measure for multiple sclerosis | Multiple Sclerosis Journal | 2017 | 562 |
| 7 | Differential diagnosis of suspected multiple sclerosis: a consensus approach | Multiple Sclerosis Journal | 2008 | 560 |
| 8 | Blood-brain barrier disruption in multiple sclerosis | Multiple Sclerosis Journal | 2003 | 547 |
| 9 | Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls | Multiple Sclerosis Journal | 2008 | 535 |
| 10 | Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters | Multiple Sclerosis Journal | 2002 | 529 |
| 11 | Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients | Multiple Sclerosis Journal | 2004 | 487 |
| 12 | New insights into the burden and costs of multiple sclerosis in Europe | Multiple Sclerosis Journal | 2017 | 472 |
| 13 | Physical activity and multiple sclerosis: a meta-analysis | Multiple Sclerosis Journal | 2005 | 458 |
| 14 | ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis | Multiple Sclerosis Journal | 2018 | 458 |
| 15 | Prevalence and treatment of spasticity reported by multiple sclerosis patients | Multiple Sclerosis Journal | 2004 | 455 |
| 16 | Patient perception of bodily functions in multiple sclerosis: gait and visual function are the most valuable | Multiple Sclerosis Journal | 2008 | 431 |
| 17 | Gait and balance impairment in early multiple sclerosis in the absence of clinical disability | Multiple Sclerosis Journal | 2006 | 427 |
| 18 | Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration | Multiple Sclerosis Journal | 2003 | 424 |
| 19 | Effects of a short-term exercise training program on aerobic fitness, fatigue, health perception and activity level of subjects with multiple sclerosis | Multiple Sclerosis Journal | 2002 | 422 |
| 20 | Myelin water imaging in multiple sclerosis: quantitative correlations with histopathology | Multiple Sclerosis Journal | 2006 | 414 |
| 21 | The Fatigue Scale for Motor and Cognitive Functions (FSMC): validation of a new instrument to assess multiple sclerosis-related fatigue | Multiple Sclerosis Journal | 2009 | 411 |
| 22 | Fatigue in multiple sclerosis and its relationship to depression and neurologic disability | Multiple Sclerosis Journal | 2000 | 409 |
| 23 | Quality of life in multiple sclerosis: the impact of depression, fatigue and disability | Multiple Sclerosis Journal | 2001 | 409 |
| 24 | The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review | Multiple Sclerosis Journal | 2015 | 381 |
| 25 | Fatigue associated with multiple sclerosis: diagnosis, impact and management | Multiple Sclerosis Journal | 2003 | 369 |
| 26 | The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines | Multiple Sclerosis Journal | 2007 | 368 |
| 27 | Review: Multiple sclerosis and physical exercise: recommendations for the application of resistance-, endurance- and combined training | Multiple Sclerosis Journal | 2008 | 360 |
| 28 | The Rao’s Brief Repeatable Battery and Stroop test: normative values with age, education and gender corrections in an Italian population | Multiple Sclerosis Journal | 2006 | 343 |
| 29 | Anxiety disorders and their clinical correlates in multiple sclerosis patients | Multiple Sclerosis Journal | 2007 | 342 |
| 30 | Altered M1/M2 activation patterns of monocytes in severe relapsing experimental rat model of multiple sclerosis. Amelioration of clinical status by M2 activated monocyte administration | Multiple Sclerosis Journal | 2011 | 330 |
| 31 | Effect of exercise training on quality of life in multiple sclerosis: a meta-analysis | Multiple Sclerosis Journal | 2008 | 322 |
| 32 | Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients | Multiple Sclerosis Journal | 2009 | 319 |
| 33 | Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis | Multiple Sclerosis Journal | 2008 | 312 |
| 34 | The Nine-Hole Peg Test as a manual dexterity performance measure for multiple sclerosis | Multiple Sclerosis Journal | 2017 | 310 |
| 35 | Screening for cognitive impairment in multiple sclerosis using the Symbol Digit Modalities Test | Multiple Sclerosis Journal | 2007 | 297 |
| 36 | Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial | Multiple Sclerosis Journal | 2014 | 295 |
| 37 | Disease steps in multiple sclerosis: a longitudinal study comparing Disease Steps and EDSS to evaluate disease progression | Multiple Sclerosis Journal | 1999 | 294 |
| 38 | Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire | Multiple Sclerosis Journal | 2003 | 292 |
| 39 | High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women | Multiple Sclerosis Journal | 2012 | 291 |
| 40 | The Goldman Consensus statement on depression in multiple sclerosis | Multiple Sclerosis Journal | 2005 | 290 |
| 41 | Cytokine and chemokine profiles in neuromyelitis optica: significance of interleukin-6 | Multiple Sclerosis Journal | 2010 | 285 |
| 42 | Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis | Multiple Sclerosis Journal | 2016 | 284 |
| 43 | The intrathecal, polyspecific and oligoclonal immune response in multiple sclerosis | Multiple Sclerosis Journal | 1998 | 283 |
| 44 | Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosis | Multiple Sclerosis Journal | 2003 | 281 |
| 45 | Demographic and clinical features of neuromyelitis optica: A review | Multiple Sclerosis Journal | 2015 | 278 |
| 46 | Multiple sclerosis in childhood: clinical features of 149 cases | Multiple Sclerosis Journal | 1997 | 275 |
| 47 | A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview | Multiple Sclerosis Journal | 2015 | 273 |
| 48 | Evaluation of the Modified Fatigue Impact Scale in four different European countries | Multiple Sclerosis Journal | 2005 | 271 |
| 49 | Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis | Multiple Sclerosis Journal | 2017 | 270 |
| 50 | Multiple sclerosis and depression | Multiple Sclerosis Journal | 2011 | 269 |
